Cannabinoid Biosynthesis Market Players:
- Amyris, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Willow Bioscience Inc.
- Cronos Group
- Zymergen Inc.
- Constellation Brands, Inc.
- Jazz Pharmaceuticals plc
- Canopy Growth Corporation
- InMed Pharmaceuticals Inc.
- Hyasynth Biologicals Inc.
- Renew Biopharma, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cannabinoid biosynthesis is estimated at USD 29.63 billion.
The global cannabinoid biosynthesis market size was more than USD 25.88 billion in 2025 and is anticipated to grow at a CAGR of over 16.1%, reaching USD 115.16 billion revenue by 2035.
Asia Pacific industry is predicted to hold the largest revenue share by 2035, impelled by rising cases of depression and anxiety expanding the use of medical marijuana.
Key players in the market include Amyris, Inc., Willow Bioscience Inc., Cronos Group, Zymergen Inc., Constellation Brands, Inc., Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc., Hyasynth Biologicals Inc., Renew Biopharma, Inc.
